Diagnostic composition and kit for renal cell carcinoma
US8278058B2 · kind B2 · utility
0Cited by
1References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 6, 2008 |
| Grant date | Oct 2, 2012 |
| Priority date | — |
| Expiry date | Mar 18, 2029 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/91017
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Disclosed herein are a composition and a kit for diagnosing renal cell carcinoma. The composition and kit employ, as a renal cell carcinoma marker, nicotinamide N-methyltransferase, L-plastin, secretagogin, NM23A, CapG, which is an actin regulatory protein, and/or C4a anaphylatoxin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.